Watch our latest webinars below or view webinars from previous years. 

Preventing Liver Cancer By Increasing Access to Hepatitis B Treatments

October is Liver Cancer Awareness Month in the United States. Left untreated, nearly 1 in 4 people living with chronic hepatitis B develop serious liver problems or liver cancer. Hepatitis B treatments are highly effective in preventing liver damage and liver cancer, but several barriers prevent equitable access to these life-saving medications. Panelists discussed discriminatory methods utilized by insurance companies that may discourage people living with hepatitis B from choosing an insurance plan, the role of copay accumulators in treatment access, tools and resources to access affordable hepatitis B treatment, and actions that patients can take to decrease the burden of adverse drug tiering.

Presentation Slides:

Barriers to Treatment Access and Patient Assistance Resources; Michaela Jackson

Copay Accumulator Adjustment Policies: Creating Barriers to Treatment; Stephanie Hengst

Role of a Patient Navigator; Mary Chiang and Jiehui Zhu

Cost-Effectiveness of a One-Time Universal Hepatitis B Screening in the U.S.

In the U.S., an estimated 2.4 million people are living with chronic hepatitis B infection. Despite CDC and U.S. Preventive Services Task Force recommendations to screen adults at high risk for infection that have been in place for over a decade, a significant majority of people (~65-75%) remain undiagnosed. With current screening practice, 33% of people are diagnosed, 36% are linked to care and 18% of the diagnosed are receiving treatment. This webinar provides background on current screening practice, barriers and challenges and discusses results of a study to assess the economic and public health impact of a one-time universal screening of the general adult population for chronic hepatitis B infection in the U.S.

Presentation Slides:
Cost-Effectiveness of Universal Screening for CHB in Adults; Mehlika Toy

Hepatitis B Educational Resources for African Communities

Panelists from the CDC and African Services Committee discuss Know Hepatitis B Campaign resources for community health workers working within African communities and community-based hepatitis B prevention initiatives. Additionally, hepatitis B activist and storyteller Bright Ansah shares his personal experiences with hepatitis B and highlight the need for greater awareness, education, and resources about hepatitis B in African communities.

Presentation Slides:
Hepatitis B Educational Resources for People of African Origin; Kari Sapsis
African Services Committee; Danait Yemane
Video: Bright's Story

Advancing Health Equity Through Adult Hepatitis B Vaccination 

This virtual briefing recognizes National Adult Hepatitis B Vaccination Awareness Day (April 30). Panelists discuss how we can work towards achieving health equity by increasing adult hepatitis B vaccination rates. In the US, just 25% of adults are fully vaccinated against hepatitis B infection. The expert panel includes representatives from the community, clinical, and federal sectors.

Presentation Slides Here


  • Mark K. Weng MD, MSc, FAAP, Medical Epidemiologist, CDC
  • Rita Kuwahara, MD, MIH, Internal Medicine, Connecticut Institute for Communities, Inc.
  • Abby Bownas, Manager, Adult Vaccine Access Coalition 
  • Judith Feinberg, MD, Professor of Behavioral Medicine and Psychiatry, Professor of Medicine/Infectious Diseases, Dr. E.B. Flink Vice Chair of Medicine for Research
  • Y-Uyen Le Nguyen, MD, Hepatitis B Program Director, Charles B Wang Community Health Center 
  • Patricia Jones, MD, Assistant Professor of Clinical Medicine, Division of Digestive Health and Liver Diseases, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine
  • Monde Nyambe, CHES, Hepatitis B Coordinator, IPHA Americorps Member 

Expanding Access to Hepatitis B Vaccination

This session shares strategies to expand hepatitis B vaccination. This webinar features a recent effort to expand vaccination uptake at a community health center in Seattle, Washington, led by Dr. Chia Wang.

Presentation Slides:
The HIT-B Project: Reducing Hepatitis B Disparities through Health Information Technology; Chia Wang

The Global Impact of the COVID-19 Pandemic on Hepatitis B Prevention and Treatment Services

Panelists discuss the short and possible long-term impacts of the global pandemic on hepatitis B initiatives, including disruptions to prevention, diagnosis, and treatment services, that potentially threaten global hepatitis B elimination goals. Speakers also share local experiences and recommendations on strategies to mitigate the impact of the COVID-19 pandemic.

Presentation Slides:
Impact of COVID-19 on the Prevention, Diagnosis and Treatment of Hepatitis B; Philippa Matthews and Caitlin Pley
Access to Health Care for Vulnerable Groups; Arafat Bwambale Introductory Video

BMJ Global Health Article: The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection

Linkage to Care and Treatment for Persons with Hepatitis B in Tanzania

This session focuses on a project that was conducted to link people living with chronic hepatitis B in Dar es-Salaam and Zanzibar, Tanzania to care and treatment. Panelists share the background and history of the project, the process of data collection, the design and implementation of interventions, and future research and opportunities.

Presentation Slides:
Linkage to Care and Treatment for Persons with Hepatitis B in Dar es-Salaam and Zanzibar, Tanzania; Brian McMahon and Shuan Shadaker

Understanding Clinical Trials

This session shares patient and provider experiences related to clinical trials for hepatitis B and hepatitis Delta as well as resources for helping patients around the world identify clinical trials.

Presentation Slides:
Joe's Story; Joe Balestreri
History of HBV Drug Trials and Current Treatment Prospect for the Road to a Cure; Hie-Won Hann
National Library of Medicine Resources and ClinicalTrials.gov; Mid-Atlantic Region, Erin Seger

Hepatitis B Clinical Trials Guide and Finder

Elevating the Patient Voice: Perspectives and Experiences of Individuals Living with Hepatitis B

Panelists report on the first hepatitis B externally-led patient-focused drug development meeting held in collaboration with the U.S. Food and Drug Administration, discuss results from an international hepatitis B patient survey, and share preliminary data from focused interviews.

Presentation Slides:
Findings from the Externally Led Patient-Focused Drug Development Meeting on Chronic Hepatitis B; Chari Cohen
David's Story; David Urick
The Patient Voice; Yasmin Ibrahim

Externally Led Patient-Focused Drug Development Meeting Report

Community Information on the Progress Towards a Hepatitis B Cure

This webinar, co-hosted by Hepatitis B Foundation and ICE-HBV, discussed research updates on the progress towards a hepatitis B cure, the impact hepatitis B has on those living with hepatitis B, and resources to learn, advocate and connect with the hepatitis B movement. Dr. John Tavis, Dr. Chari Cohen, Dr. Jake Liang, and Dr. Su Wang are each featured within this informative panel.

Presentation Slides: HBVCureWebinar.pptx


Improving Hepatitis B Awareness, Screening, Vaccination, and Linkage to Care Among LGBTQ Communities

Panelists discuss efforts to improve hepatitis B awareness, screening, vaccination, and linkage to care among LGBTQ communities. Speakers share efforts to raise hepatitis B awareness, testing, and vaccination among the MSM Latinx community in King County, Washington and the CDC’s Division of Viral Hepatitis share resources to promote hepatitis A and B vaccination among MSM communities.

Presentation Slides:
An Overview of Hepatitis B in the LatinX MSM Community; Anthony Le and Lésster Munguia
Communication Materials for Gay and Bisexual Men; Amanda Carnes

Legal Protections Against Hepatitis-Based Discrimination in Healthcare Education

Panelists discuss cases of discrimination against health care students with hepatitis B, preliminary research findings from an analysis of health professions school admissions policies in two jurisdictions, federal legal protections, and the process for filing complaints.

Presentation Slides:
Background History: Discrimination Against Healthcare Students with Chronic HBV; Nadine Shiroma
Hepatitis B and the ADA; Susana Lorenzo-Giguere
Assessment: Pennsylvania and New York City Health Professions Schools; Daniel Alohan and Kate Moraras

Updated CDC Recommendations for the Management of Hepatitis B Virus-Infected Healthcare Providers and Students
U.S. Department of Justice Settlement Agreement (2013)
Joint Agency Letter to Health Professions Schools

Expanding Knowledge Related to Hepatitis B Among Nail Salon Workers in the U.S.

Join this session to discuss barriers and knowledge associated with hepatitis B in the Vietnamese nail salon worker community. This webinar features a recent effort led by Drexel University’s Dornsife School of Public Health, Hep B United Philadelphia, and VietLead on outreach strategies within Vietnamese-owned nail salons in Greater Philadelphia to improve overall health for the community.

Presentation Slides:
Development of the Healthy Nail Salon Project in Philadelphia; Tran Huynh, Nancy Nguyen, Nga Vu, and Tracy Nguyen

Overcoming Barriers to Adult Hepatitis B Vaccination

Join us for a virtual briefing on April 30th, National Adult Hepatitis B Vaccination Awareness Day, to discuss overcoming barriers to adult hepatitis B vaccination. 75% of adults in the U.S. are NOT protected against hepatitis B, the leading cause of liver cancer worldwide. Panelists include experts at the federal, state, and local levels who are working to increase awareness and access to hepatitis B vaccination among adults.

Presentation Slides:
National Adult Hepatitis B Vaccination Awareness Day (HBF); Rhea Racho
Hepatitis B: A Preventable Infection and Public Health Problem (CDC); Noele Nelson
Challenges with HBV Vaccination of High-Risk Adults: Advancing National & Local Infrastructure (NASTAD); Boatemaa Ntiri-Reid
Increasing Adult Hepatitis B Vaccination in Vulnerable Communities Through a Comprehensive Harm Reduction Approach (HEP); Jason Sterne
We Can't Know the Future, But We Can Protect Ourselves From It; Camilla Graham

Hepatitis Awareness Month: Planning Creative and Impactful Virtual Outreach Efforts

This session discusses innovative, online strategies to raise awareness about hepatitis throughout May. CDC’s Division of Viral Hepatitis shares resources that are available to promote testing. Community partners provide an overview of activities including the impact of COVID-19 on programs, strategies to transition community testing events to virtual activities, increasing social media presence, online hepatitis B education, and discuss their plans for this year’s Hepatitis Awareness Month and Testing Day.

Presentation Slides:
Hep B United Philadelphia; Catherine Freeland
Hepatitis B Initiative of Washington DC; Jane Pan
Hep Free NYC; Nirah Johnson
Hep Free Hawaii; Thaddeus Pham
CDC Hepatitis Awareness Month Resources; Amanda Carnes

Improving Diversity in Clinical Trials for Hepatitis B Treatments

This session discusses why representation, including of persons living with hepatitis B, is essential to research, and communication and outreach strategies to improve diversity in clinical trials. Christine Lee, PharmD, PhD, from the U.S. Food & Drug Administration (FDA) provides an overview of clinical trials recruitment and strategies to improve participation and Rhea Racho, MPAff, discusses the Hepatitis B Foundation's participation in the National Institute of Health's All of Us Research Program and how the program is working to make medical research more inclusive.

Presentation Slides:
FDA Office of Minority Health and Health Equity; Christine Lee
All of Us Research Program; Rhea Racho

HBF Clinical Trials Finder
HBV Drug Watch

Innovative Outreach Strategies for Hepatitis B: Lessons from HBU Grantees

Hepatitis B experts and past Hep B United mini-grant recipients around the country share innovative approaches to hepatitis B outreach. Three expert panelists from the Immunize Colorado, Korean Community Services in New York, and Midwest Asian Health Association from Chicago will report on strategies for hard to reach populations and hepatitis B.

Presentation Slides:
Immunize Colorado; Kristin Mlynarczyk
KCS Hep B Outreach: Reaching Faith Leaders and Patients in the Korean Community; Paul Lee
Hepatitis B Mentorship Program for Bangladeshi Community in Michigan; Hong Liu

Hepatitis Delta Treatment Endpoints: How Do We Measure Success in the Era of Emerging Therapies?

Hepatitis delta expert, Dr. Ohad Etzion, outlines the challenges in controlling the disease, current clinical trials, and explores ideal endpoints for treatment and control of hepatitis B and delta co-infection.

Presentation Slides:
Hepatitis D Treatment Endpoints: How Do We Measure Success in the Era of Emerging Therapies?